A 57-Year-Old Woman With Ovarian Cancer

home / case-based-peer-perspectives / a-57-year-old-woman-with-ovarian-cancer

Lyndsay Willmott, MD, discusses the case of a 57-year-old woman with ovarian cancer and the available treatment options.

Case Presentation: A 57-Year-Old Woman With Ovarian Cancer

EP. 1: Case Presentation: A 57-Year-Old Woman With Ovarian Cancer

Lyndsay Willmott, MD
September 23rd 2021

Lyndsay Willmott, MD, presents the case of a 57-year-old woman with ovarian cancer.

Watch

Molecular Testing: Ovarian Cancer

EP. 2: Molecular Testing: Ovarian Cancer

Lyndsay Willmott, MD
September 23rd 2021

An oncologist explains the importance of molecular testing in ovarian cancer and the implications of testing on treatment selection.

Watch

First-Line Therapies in Ovarian Cancer

EP. 3: First-Line Therapies in Ovarian Cancer

Lyndsay Willmott, MD
September 23rd 2021

Dr. Lyndsay Willmott discusses the front-line therapy options for ovarian cancer and the factors considered in choosing maintenance therapies.

Watch

Rucaparib Maintenance Therapy in Ovarian Cancer: The ARIEL3 Trial

EP. 4: Rucaparib Maintenance Therapy in Ovarian Cancer: The ARIEL3 Trial

Lyndsay Willmott, MD
September 23rd 2021

A key opinion leader shares data from a phase III, ARIEL3, clinical trial on rucaparib maintenance treatment for ovarian cancer.

Watch

Toxicities With PARP Inhibitors for Ovarian Cancer

EP. 5: Toxicities With PARP Inhibitors for Ovarian Cancer

Lyndsay Willmott, MD
September 23rd 2021

Lyndsay Willmott, MD, explains the tolerability of PARP inhibitors for ovarian cancer and how to discuss dose reductions with patients.

Watch

Future Treatments in Ovarian Cancer

EP. 6: Future Treatments in Ovarian Cancer

Lyndsay Willmott, MD
September 23rd 2021

An expert reviews the ongoing ARIEL4 phase III trial and explains what the future of ovarian cancer treatment looks like.

Watch